Cutaneous Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Cutaneous Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors [Phase 1]
Phase I trial update of Tolododekin Alfa (ANK-101) in advanced solid tumors. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Flash Radiotherapy for Skin Cancer [Phase 2]
Phase 2 trial of flash radiotherapy for skin cancers is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial update evaluating INCB099280 in participants with advanced cutaneous squamous cell carcinoma.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy [Phase 4]
A Phase 4 clinical trial update for cosibelimab in cutaneous squamous cell carcinoma in patients with kidney transplant or hematologic malig…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39) [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab formulated with berahyaluronidase alfa (MK-5180) in Japanese participants with recurrent or …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: TIL Therapy in cSCC and MCC [Phase 2]
A Phase 2 clinical trial evaluating tumor-infiltrating lymphocyte therapy for cutaneous squamous cell carcinoma and Merkel cell carcinoma is…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Ex Vivo Cutaneous SCC [NA]
A clinical trial update indicates recruiting for an ex vivo study related to cutaneous squamous cell carcinoma at Rigshospitalet in Denmark,…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Exercise to Boost Response to Checkpoint Blockade Immunotherapy [EARLY_Phase 1]
This clinical trial update describes an Early Phase 1 study at H. Lee Moffitt Cancer Center examining whether exercise can boost responses t…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Pucotenlimab Combined With Becotatug Vedotin in Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating the combination of pucotenlimab and becotatug vedotin for advanced c…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Correlation of Dermoscopic Findings With Histopathological Features and Invasion Depth in Cutaneous Squamous Cell Carcinoma
This clinical trial study investigates the correlation between dermoscopic features and histopathological invasion depth in cutaneous squamo…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC [Phase 1]
Phase 1 trial evaluating radiotherapy in combination with atezolizumab for locally advanced, borderline resectable, or unresectable cutaneou…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications [Phase 1]
A Phase 1 clinical trial update describes evaluation of BBI-355 (CHK1 inhibitor) in combination with BBI-825 (RNR inhibitor) for tumors with…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence
A clinical trial update evaluating whether preoperative high-frequency ultrasound assessment of skin lesion extent reduces excision-margin p…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma [Phase 1]
Phase 1 clinical trial update of intralesional cemiplimab in adults with cutaneous squamous cell carcinoma or basal cell carcinoma has compl…
-
EMA approval · 2026-01-20EMA Authorised: Libtayo (cemiplimab) — Regeneron Ireland Designated Activity Company (DAC)
The European Medicines Agency authorised Libtayo (cemiplimab) for the treatment of cutaneous squamous cell carcinoma (CSCC). Regeneron Irela…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma [NA]
A clinical study evaluating stereotactic post-operative radiotherapy for intraparotid metastatic cutaneous squamous cell carcinoma is curren…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating in situ immunomodulation using CDX-301, CDX-1140, and Poly-ICLC with radiation therapy in patients with unresecta…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region
A completed clinical trial evaluated decisional conflicts, health-related quality of life, and satisfaction with care for patients with high…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Thermotherapy in Addition to SOC Palliative Radiotherapy [NA]
A clinical trial update indicating recruitment for a study evaluating thermotherapy added to standard of care palliative radiotherapy in pat…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
A clinical trial update announcing a liquid biomarker study in melanoma and non-melanoma skin cancers that is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma [Phase 2]
Phase 2 neoadjuvant trial evaluating the combination of nivolumab and relatlimab for cutaneous squamous cell carcinoma is currently recruiti…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
Clinical trial update on tumor-informed ctDNA testing for minimal residual disease after treatment in head and neck squamous cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer [Phase 2]
A Phase 2 trial evaluating Vidutolimod in combination with cemiplimab for adults with advanced or metastatic cancers was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma [Phase 1]
The document describes a Phase 1 neoadjuvant trial of cemiplimab (Libtayo) for Merkel cell carcinoma and locoregionally advanced cutaneous s…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer [Phase 1]
Phase 1 clinical trial evaluating MQ710 with and without pembrolizumab in solid tumors; the study is currently recruiting.